Definitive Contract 75N91020C00033
Award Date
9/16/20
Potential Completion Date
9/15/21
Potential Value
$361K
Federal Agency
National Cancer Institute
Awardee
Avident Health LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20003, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
21
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This SBIR Phase I contract was awarded by the National Institutes of Health National Cancer Institute to Outcomes4Me Inc. for $452,514. The contract is for the period of September 16, 2020 through September 15, 2022 and involves developing mobile health technology to utilize cancer survivorship navigation for patient benefit. The solicitation sought proposals to conduct research and development in support of NIH and CDC agency missions, including topics related to cancer immunotherapy...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The $225,000 Firm Fixed Price contract was awarded to Dimagi Inc., a self-certified small disadvantaged business, to develop a digital health solution to support long-term cancer survivorship using patient navigation. The contract is part of the NCI Cancer Moonshot program. Dimagi...
This definitive contract was awarded by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to Intelligent Automation, LLC. The $399,980 firm fixed price contract is for Phase I of the SBIR program's TOPIC 412, which seeks the development of a wearables-agnostic platform for continuous health monitoring and predictions to support cancer patients. The one-year period of performance will take place in Derwood,...
This SBIR Phase I contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Navipoint Genomics LLC, a minority-owned and Asian-Pacific American-owned limited liability company. The $251,927 firm-fixed-price contract is for the development of cloud-based software in support of the Cancer Research Data Commons. This contract was issued under the total small business set-aside NIH SBIR solicitation PHS-2020-1, which...
This is a $399,992 firm fixed price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Xanthoshealth, Inc., a small business concern, to develop "Software to Address Social Determinants of Health in Oncology Practices" under the NCI's SBIR program. The original solicitation sought proposals for innovative research across various biomedical and public health topics, including digital health tools, to contribute towards the NCI and Centers for Disease Control and...
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $453,123 Small Business Innovation Research (SBIR) Phase I contract to Pistevo Decision LLC, a minority-owned small business, to develop an integrated multi-level decision support platform to address patient-centered and evidence-based social determinants of health among cancer patients. This Phase I contract is part of a two-year $2 million SBIR Phase II award granted to Pistevo in September 2023....
This definitive contract from the Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH) is valued at $377,061 to Broad Axe Care Coordination LLC Locus Healtlh Division, doing business as Locus Health. It concerns SBIR Phase I Topic 406 to develop a cancer navigation platform, as requested in the National Institutes of Health and Centers for Disease Control and Prevention's solicitation for Small Business Innovation Research proposals. The...
<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
This is a $399,062 firm-fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Avoneaux Medical Institute, LLC for the development of spatial micro-purification technology. The contract was set aside for small businesses and is part of the NCI's broader SBIR program, which funds research and development in support of the NIH and CDC's mission needs. The original solicitation sought proposals on a range of cancer-related topics, including alternatives to cell...
This is a $399,870 firm-fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Apricity Health LLC, a small business based in Houston, Texas. The contract is for the development of "Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement" under a total small business set-aside solicitation. The original solicitation, PHS-2020-1, sought proposals from small businesses for SBIR...